Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: J05AE01

Fortovase(saquinavir)

HIV Infections

Marketing Authorisation Holder: Roche Registration Ltd.

EMA Authorisation: 20/08/1998

INN: saquinavir

Indication

Fortovase is indicated for treatment of HIV-1 infected adult patients. Fortovase should only be given in combination with ritonavir and other antiretroviral medicinal products (see section 4.2).

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Fortovase — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.